CVRx, Inc. (CVRX)
NASDAQ: CVRX · Real-Time Price · USD
8.18
-0.04 (-0.49%)
Mar 3, 2026, 4:00 PM EST - Market closed
CVRx, Inc. Revenue
In the year 2025, CVRx, Inc. had annual revenue of $56.65M with 10.45% growth. CVRx, Inc. had revenue of $16.02M in the quarter ending December 31, 2025, with 4.45% growth.
Revenue (ttm)
$56.65M
Revenue Growth
+10.45%
P/S Ratio
3.80
Revenue / Employee
$254,040
Employees
223
Market Cap
215.23M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 56.65M | 5.36M | 10.45% |
| Dec 31, 2024 | 51.29M | 12.00M | 30.53% |
| Dec 31, 2023 | 39.30M | 16.83M | 74.89% |
| Dec 31, 2022 | 22.47M | 9.43M | 72.36% |
| Dec 31, 2021 | 13.04M | 6.98M | 115.36% |
| Dec 31, 2020 | 6.05M | -204.00K | -3.26% |
| Dec 31, 2019 | 6.26M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Inogen | 348.67M |
| InfuSystem Holdings | 143.44M |
| Sight Sciences | 76.05M |
| Electromed | 68.86M |
| 908 Devices | 65.05M |
| SANUWAVE Health | 41.28M |
| Rapid Micro Biosystems | 30.52M |
| Profound Medical | 14.30M |
CVRX News
- 1 day ago - CVRx Announces Late-Breaking Data and Scientific Presentations Highlighting Barostim Outcomes at the THT 2026 Annual Meeting - GlobeNewsWire
- 19 days ago - CVRx, Inc. (CVRX) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - CVRx to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call on February 12, 2026 - GlobeNewsWire
- 5 weeks ago - CVRx Kicks Off One Of The Largest Heart Device Trials In History - Benzinga
- 5 weeks ago - CVRx Announces Initiation of BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population - GlobeNewsWire
- 6 weeks ago - CVRx, Inc. (CVRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 7 weeks ago - CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2025 Financial Results and Issues Fiscal 2026 Guidance - GlobeNewsWire
- 2 months ago - CVRx Announces Implementation of New Category I CPT Codes for Barostim Therapy - GlobeNewsWire